Dabigatran and warfarin: comparative analysis of safety and cost.

被引：0
|
作者：
Vakil, Niyati H. [1 ]
Leber, Molly [1 ]
Bliss, Gina [1 ]
Yazdi, Marina [1 ]
机构：
[1] Yale New Haven Med Ctr, New Haven, CT 06504 USA
来源：
PHARMACOTHERAPY | 2012年 / 32卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
6E
引用
收藏
页码：E179 / E179
页数：1
相关论文
共 50 条
  • [1] Comparative Effectiveness and Clinical Safety Between Dabigatran, Rivaroxaban, and Warfarin
    Lai, Chao-Lun
    Chen, Ho-Min
    Lin, Ting-Tse
    Liao, Min-Tsun
    Chan, K. Arnold
    CIRCULATION, 2016, 134
  • [2] Comparative Effectiveness and Clinical Safety Between Dabigatran, Rivaroxaban, and Warfarin
    Lai, Chao-Lun
    Chen, Ho-Min
    Lin, Ting-Tse
    Liao, Min-Tsun
    Chan, K. Arnold
    CIRCULATION, 2016, 134
  • [3] COST ANALYSIS OF SAFETY OUTCOMES OF DABIGATRAN VS. WARFARIN IN THE SPANISH NATIONAL HEALTH SERVICE
    Sole, A.
    Male, N.
    Manganelli, A.
    Serra-Burriel, M.
    VALUE IN HEALTH, 2018, 21 : S101 - S101
  • [4] COST ANALYSIS OF SUBSTITUTING DABIGATRAN FOR WARFARIN IN AN ANTICOAGULATION MANAGEMENT SERVICE
    Atay, Julie
    Fiumara, Karen
    Piazza, Gregory
    Fanikos, John
    Goldhaber, Samuel Z.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 57 (14) : E1188 - E1188
  • [5] META-ANALYSIS OF SAFETY OF DABIGATRAN AND WARFARIN FOR ATRIAL FIBRILLATION
    Aggarwal, S.
    Kumar, S.
    Segal, J.
    VALUE IN HEALTH, 2014, 17 (03) : A105 - A106
  • [6] META-ANALYSIS FOR SAFETY OF DABIGATRAN AND WARFARIN FOR TREATMENT OF ATRIAL FIBRILLATION
    Aggarwal, S.
    Topaloglu, H.
    Messenger, M.
    VALUE IN HEALTH, 2013, 16 (03) : A274 - A274
  • [7] META-ANALYSIS OF SAFETY OF DABIGATRAN AND WARFARIN FOR TREATMENT OF ATRIAL FIBRILLATION
    Aggarwal, S.
    Segal, J.
    VALUE IN HEALTH, 2013, 16 (07) : A515 - A515
  • [8] A Comparative Analysis of Models Used to Evaluate the Cost-Effectiveness of Dabigatran Versus Warfarin for the Prevention of Stroke in Atrial Fibrillation
    Sorensen, Sonja V.
    Peng, Siyang
    Monz, Brigitta U.
    Bradley-Kennedy, Carole
    Kansal, Anuraag R.
    PHARMACOECONOMICS, 2013, 31 (07) : 589 - 604
  • [9] A Comparative Analysis of Models Used to Evaluate the Cost-Effectiveness of Dabigatran Versus Warfarin for the Prevention of Stroke in Atrial Fibrillation
    Sonja V. Sorensen
    Siyang Peng
    Brigitta U. Monz
    Carole Bradley-Kennedy
    Anuraag R. Kansal
    PharmacoEconomics, 2013, 31 : 589 - 604
  • [10] Comparative effectiveness and safety of warfarin and dabigatran in patients with non-valvular atrial fibrillation in Japan: A claims database analysis
    Koretsune, Yukihiro
    Yamashita, Takeshi
    Yasaka, Masahiro
    Ono, Yasuhisa
    Hirakawa, Takeshi
    Ishida, Kosuke
    Kuroki, Daisuke
    Sumida, Toshiyuki
    Urushihara, Hisashi
    JOURNAL OF CARDIOLOGY, 2019, 73 (3-4) : 204 - 209
12345